Product NDC: | 68682-302 |
Proprietary Name: | Pyridostigmine Bromide |
Non Proprietary Name: | Pyridostigmine Bromide |
Active Ingredient(s): | 60 mg/1 & nbsp; Pyridostigmine Bromide |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68682-302 |
Labeler Name: | Oceanside Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA009829 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20071030 |
Package NDC: | 68682-302-10 |
Package Description: | 100 TABLET in 1 BOTTLE (68682-302-10) |
NDC Code | 68682-302-10 |
Proprietary Name | Pyridostigmine Bromide |
Package Description | 100 TABLET in 1 BOTTLE (68682-302-10) |
Product NDC | 68682-302 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Pyridostigmine Bromide |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20071030 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Oceanside Pharmaceuticals |
Substance Name | PYRIDOSTIGMINE BROMIDE |
Strength Number | 60 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |